False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis

Abstract

The object of this study was to determine the incidence of seropositivity to B. burgdorferi by the commonly available enzyme-linked immunosorbent assay (ELISA) in patients with SLE and other rheumatic diseases and to evaluate immunoblot analysis as a tool to differentiate true from false positive ELISA. Sera were obtained from patients with SLE (n = 35), rheumatoid arthritis (n = 26), seronegative arthritis (n = 28) and Lyme disease (n = 18). Reactivity to B. burgdorferi antigens was analysed by two available diagnostic techniques: ELISA and immunoblot. Correlations were made between seroreactivity to B. burgdorferi and standard serological tests of autoimmunity: antibodies to nuclear antigens, dsDNA, cardiolipin, SSA and SSB. Seroreactivity to B. burgdorferi antigens by the ELISA system was detected in 40% of patients with SLE, 8% of patients with rheumatoid arthritis and 4% with seronegative arthritis. Among patients seropositive by ELISA, immunoblots were negative in all cases. However, eight of 14 patients with rheumatoid arthritis (57%) showed cross-reactivity to multiple borrelial antigens. No significant correlations were found between Lyme seropositivity by ELISA and other autoantibodies except IgM rheumatoid factor (r = 0.61, P < 0.01 ) in patients with rheumatoid arthritis.

In conclusion: a positive ELISA for Lyme disease was found in up to 40% of patients with established SLE and also in other rheumatic diseases. However, specific serum antibodies to Borrelia were not confirmed by the more specific immunoblot technique. We conclude that immunoblot analysis can help differentiate a false from true positive ELISA for Lyme disease. These findings should caution the clinician with regard to the limitations of current diagnostic testing for Lyme disease, particularly in patients with connective tissue disease.

Keywords

lyme disease SLE rheumatic disease serologic testing ELISA

Get full access to this article

View all access options for this article.

References

Burgdorfer W. , Barbour AG , Hayes SF et al. Lyme disease: a tick born spirochetosis? Science 1982; 216: 1317-19.

Sigal LH Lyme disease: a worldwide borreliosis. Clin Exp Rheumatol 1989; 6: 411-21.

Steere AC Lyme disease. New Engl J Med 1989; 321: 586-96.

Steere AC , Malawista SE , Snydman DR Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20: 7-17.

Steerre AC , Grodzicki RL , Kornblatt AN et al. The spirochetal etiology of Lyme disease. New Engl J Med 1983; 308: 733-40.

Steere AC , Schoen RT , Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987; 107: 725-31.

Sigal LH Summary of the first one hundred patients seen at a Lyme disease referral center. Am J Med 1990; 88: 577-81.

Hedberg CW , Osterholm MT , MacDonald KL et al. An interlaboratory study of antibody to Borrelia burgdorferi . J Infect Dis 1987; 155: 1325-7.

Schwartz BS , Goldstein MD , Ribeiro Jmc et al. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA 1989; 262: 3431-4.

10.

Lugar SW , Krauss E. Serologic tests for Lyme disease: interlaboratory variability. Arch Intern Med 1990; 150: 761-3.

11.

Sigal LH Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms. Semin Arthritis Rheum 1989; 18: 151-67.

12.

Magnarelli LA , Anderson JF Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi. Am J Epidemiol 1988; 127: 818-25.

13.

Craft JE , Grodzicki RL , Steere AC Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis 1984; 149: 789-94.

14.

Russell H. , Sampson JS , Schmid GP et al. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 1984; 149: 465-70.

15.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982; 25: 1271-7.

16.

Arnett FC , Edworthy SM , Block DA The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 ; 31: 315-24.

17.

Grodzicki RL , Steere AC Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis 1988; 157: 790-7.

18.

Karlsson M. , Mollegard I. , Stiernstedt G. et al. Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1989; 8: 871-7.

19.

Barbour AG Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57: 521-5.

20.

Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.

21.

Towbin H. , Stahelin T. , Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.

22.

Dressler F. , Whalen JA , Reinhardt BN et al. Western blotting in the serodiagnosis of Lyme disease. Arthritis Rheum 1991; 34: S113.

23.

Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.

24.

Dressler F. , Whalen JA , Reinhardt BN et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167: 392-400.

25.

Mertz LE , Wobig GH , Duffy J. et al. Ticks, spirochetes and new diagnostic tests for Lyme disease . Mayo Clin Proc 1985; 60: 402-6.

26.

Sood SK , Rubin LG , LeBlanc ME et al. Positive Lyme disease (LD) serology in juvenile rheumatoid arthritis in a LD endemic area: analysis by immunoblot. Arthritis Rheum 1991; 34: S37.

27.

Magnarelli LA , Anderson JF , Johnson RC Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis 1987; 156: 183-8.

28.

Lavoie PE , Burgdorfer W. Serologic reactivity to Borrelia burgdorferi in rheumatoid arthritis patients . Ann NY Acad Sci 1988; 539: 460-4.

29.

Steere AC et al. Chronic Lyme arthritis: clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med 1979; 90: 896-901.

30.

Hanrahan JP , Benach JL , Coleman JL et al. Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis 1984; 150: 489-96.

31.

Munchoff P. , Wilske B. , Preac-Mursic V. et al. Antibodies against Borrelia burgdorferi in Bavarian forest workers. Zentalb Bakteriol Mikrobiol Hyg [A] 1986; 263: 412-19.

32.

Steere AC , Taylor E. , Wilson MI et al. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 1986; 154: 295-300.

33.

Hansen K. , Bangsborg JM , Fjordvang H. et al. Immunochemical characterization of and isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen common to a wide range of bacteria. Infect Immun 1988 ; 56: 2047-53.

34.

Schwan TG , Rosa PA QA specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J Infect Dis 1989; 160: 1018-29.

35.

Malloy DC , Nauman RK , Paxton H. Detection of Borrelia burgdorferi using the polymerase chain reaction. J Clin Microbiol 1990; 28: 1089-93.

36.

Goodman JL , Jurkovich P. , Kramber JM et al. Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun 1991; 59: 269-78.